Document Detail


Successful management of recurrent pregnancy-related thrombotic thrombocytopaenia purpura in a renal transplant recipient.
MedLine Citation:
PMID:  20466681     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Thrombotic thrombocytopaenic purpura (TTP) is a rare but potentially devastating complication of pregnancy. We report the first documented case of a successful treatment of recurrent TTP complicating pregnancy in a renal transplant patient.
Authors:
Kimberly Lam; Vanessa Martlew; Steve Walkinshaw; Zarko Alfirevic; Matthew Howse
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2010-05-02
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  25     ISSN:  1460-2385     ISO Abbreviation:  Nephrol. Dial. Transplant.     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-06-25     Completed Date:  2010-11-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  England    
Other Details:
Languages:  eng     Pagination:  2378-80     Citation Subset:  IM    
Affiliation:
Department of Nephrology, Royal Liverpool and Broadgreen University Hospital, NHS Trust, Liverpool, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
ADAM Proteins / blood
Adult
Female
Humans
Kidney Failure, Chronic / surgery*
Kidney Transplantation*
Plasma Exchange* / methods
Pregnancy
Pregnancy Complications / blood,  therapy*
Purpura, Thrombotic Thrombocytopenic / blood,  therapy*
Recurrence
Treatment Outcome
Chemical
Reg. No./Substance:
EC 3.4.24.-/ADAM Proteins; EC 3.4.24.-/ADAMTS13 protein, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in h...
Next Document:  The decades-long fight against HBV transmission to dialysis patients: slow but definite progress.